Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study

[1] Goldhirsch A(2011)Panel members. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 1736-47

[2] Wood WC(2000)Molecular portraits of human breast tumours Nature 406 747-752

[3] Coates AS(2001)Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications Proceedings of the National Academy of Sciences of the United States of America 98 10869-10874

[4] Gelber RD(2013)Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann Oncol 24 2206-23

[5] Thürlimann B(2006)Classification of ductal carcinoma in situ by gene expression profiling Breast Cancer Res 8 R61-368

[6] Senn HJ(2010)Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer Mol Oncol 4 357-77

[7] Perou CM(2010)Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast J Natl Cancer Inst Monogr 2010 162-637

[8] Sorlie T(2010)Biomarker Expression and Risk of Subsequent Tumours After Initial Ductal Carcinoma In Situ Diagnosis J Natl Cancer Inst 102 627-10

[9] Eisen MB(2013)A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast J Natl Cancer Inst 105 701-649

[10] van de Rijn M(2010)Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study BMC Cancer 10 653-2795

[1] Goldhirsch A(2011)Panel members. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 1736-47

[2] Wood WC(2000)Molecular portraits of human breast tumours Nature 406 747-752

[3] Coates AS(2001)Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications Proceedings of the National Academy of Sciences of the United States of America 98 10869-10874

[4] Gelber RD(2013)Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann Oncol 24 2206-23

[5] Thürlimann B(2006)Classification of ductal carcinoma in situ by gene expression profiling Breast Cancer Res 8 R61-368

[6] Senn HJ(2010)Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer Mol Oncol 4 357-77

[7] Perou CM(2010)Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast J Natl Cancer Inst Monogr 2010 162-637

[8] Sorlie T(2010)Biomarker Expression and Risk of Subsequent Tumours After Initial Ductal Carcinoma In Situ Diagnosis J Natl Cancer Inst 102 627-10

[9] Eisen MB(2013)A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast J Natl Cancer Inst 105 701-649

[10] van de Rijn M(2010)Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study BMC Cancer 10 653-2795